About Nephrolytix
MISSION: 1.7 million deaths per year are caused by Acute Kidney Injury (AKI) globally. AKI is a frequent, clinical event occurring in up to 20% of all hospital patients. It is characterized by a rapid deterioration of renal function to varying degrees, and associated with an up to 15-fold higher risk of death. In addition, patients with AKI have a significantly higher risk of developing or worsening a chronic kidney disease. As of today, an early detection tool for AKI is not available.
Nephrolytix aims to close this early detection gap with an easy-to-use tool for rapid and precise kidney function measurement.
- Founding: 2021
- Focus : Manufacturer
- Employees: 1-10
- Industry : Diagnostics
Product portfolio of Nephrolytix
Here you will find Nephrolytix GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
